Cherubic Ventures customer Takeda saw an optimisation that took one to two months now takes about a week.
Public source
Publisher name
Public post
"A lab is really just a big kitchen. We provide the recipes, and we use AI to generate them, then they get tested in the lab." That's Loïc Roch, co-founder and CTO of At…
Company
Cherubic Ventures
Cherubic is a global venture capital fund investing in the most ambitious founders from angel to pre-IPO.
- Industry
- Venture Capital and Private Equity Principals
- Location
- Taipei, TW
- Company size
- 11–50 employees
About Cherubic Ventures
Cherubic Ventures is a seed stage venture capital firm investing in pre-product market fit companies globally. Cherubic currently manages $400M AUM with team members across San Francisco, Taipei, Waterloo and Tokyo. Cherubic has seeded more than 10 companies valued at over $1B including Hims & Hers(IPO), Paidy(acq by Paypal), 91APP(IPO), Ring(acq by Amazon), StarLark(acq by Zynga), Flexport, Calm, Bellabeat, Astranis, Bellabeat, Trialspark, and Photomath.
See moreLatest activity
Latest activity from Cherubic Ventures
12 signals
Research & Knowledge
Cherubic Ventures portfolio company Paravision CEO Doug Aley wrote for Liminal about what to watch over the next 12 to 18 months regarding identity security and AI attack adaptation.
Capital & Finance
Cherubic Ventures raised a $60M seed led by Felicis at a $300M valuation in February.
Customers & Market
Cherubic Ventures customer Atinary's own lab in Boston produces more data in a week than a PhD student does in five years.
Discover more
Similar signals
Similar public activity from other companies.
Customers & Market
Scale Venture Partners
Scale Venture Partners customers pulled more product from Numeric by 2022 and 2023
Customers & Market
Foundation Capital
Foundation Capital sees customers wanting the product running on their own messy data - legacy formats, incomplete records, real edge cases - before they sign anything.
Customers & Market
Obvious Ventures
Obvious Ventures partners with Bayesian Health, where Suchi Saria and her team use AI to provide real-time clinical intelligence and help clinicians identify patient risk earlier.
Customers & Market
Pruven Capital
Pruven Capital reported that its enterprise GTM strategy outperformed other VCs by providing more customers, faster delivery, and lower effort.
Customers & Market
Fly Ventures